20 July 2015, Maidenhead, UK –IAOCR, the leading provider of independently recognized, competence-based accreditation, consultancy and accredited training within the clinical research sector, is pleased to announce the pilot Clinical Operations Workforce Quality Accreditation, achievement of which will serve as a quality mark for clinical operations workforce excellence. Leading contract research organization (CRO) INC Research is the first to participate in the pilot, introduced to industry specialists at the annual IAOCR Clinical Research Industry Leaders Think Tank in June.
IAOCR has listened to the industry and responded to the demand from CROs and pharmaceutical companies by designing and developing the Clinical Research Workforce Quality Accreditation in collaboration with industry experts. The accreditation awarded at the organizational level will provide a globally consistent standard against which any organization involved in clinical research can be measured. Additionally, the clearly recognizable quality mark aims to provide reassurance and transparency to sponsors as well as differentiation for participating CROs.
The Workforce Quality Accreditation will help to reduce vendor oversight costs related to compliance checks and new and changing project staff while bolstering confidence that training and competence programs have been independently verified. The accreditation mark will provide reassurance that the achieving organization has better quality staff, which in turn improves trial efficiency and lowers costs.
“We have listened very carefully to what the sector has been crying out for and developed the Workforce Quality Accreditation to adhere to the needs of the CROs and clinical trial sponsors. For a CRO such as INC, we believe the accreditation will enhance their reputation as the contract research organization of choice. This will demonstrate their commitment to providing high quality staff that are appropriately trained and competent, ultimately leading to enhanced staff engagement, and recognition as the leader in clinical research workforce development best practices.” said Jacqueline Johnson North, CEO & Co-Founder of IAOCR.
“At INC Research, we are always looking for innovative solutions and practices that help us deliver results for our clients,” Alistair Macdonald, President & Chief Operating Officer, said. “Employees are INC’s most valued resource and we provide them with industry-leading learning and development to ensure they remain among the best of the best. INC is committed to being the CRO of choice and leading the way in IAOCR accreditation is a great step toward receiving validation for our continued efforts to deliver on this promise.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.